Mary J Lindstrom Selected Research

1 alpha-hydroxyergocalciferol (doxercalciferol)

12/2007	1 alpha-Hydroxyvitamin D2 inhibits growth of human neuroblastoma.
9/2004	Effectiveness of 1alpha-hydroxyvitamin D2 in inhibiting tumor growth in a murine transgenic pigmented ocular tumor model.
5/2002	Toxicity and dose-response studies of 1alpha-hydroxyvitamin D2 in a retinoblastoma xenograft model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mary J Lindstrom Research Topics

Disease

18	Neoplasms (Cancer) 01/2017 - 01/2002
8	Retinoblastoma (Glioblastoma, Retinal) 10/2005 - 01/2002
4	Neuroblastoma 05/2011 - 10/2005
4	Hypercalcemia (Milk Alkali Syndrome) 07/2008 - 09/2002
3	Breast Neoplasms (Breast Cancer) 06/2009 - 04/2002
3	Weight Loss (Weight Reduction) 09/2004 - 01/2002
2	Carcinoma (Carcinomatosis) 07/2006 - 01/2003
2	Carcinogenesis 07/2006 - 04/2002
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2017
1	Insulin Resistance 08/2015
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 08/2015
1	Obesity 08/2015
1	Ankylosing Spondylitis 12/2011
1	Residual Neoplasm 05/2011
1	Esophageal Neoplasms (Esophageal Cancer) 02/2011
1	Achlorhydria (Hypochlorhydria) 12/2010
1	Osteoporotic Fractures 12/2010
1	End Stage Liver Disease 11/2010
1	Overweight 03/2010
1	Prostatic Neoplasms (Prostate Cancer) 10/2009
1	Adenocarcinoma 10/2009
1	Nephrolithiasis 07/2008
1	Osteomalacia 07/2008
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 07/2008
1	Hypercalciuria 07/2008
1	Renal Insufficiency (Renal Failure) 07/2008
1	Uveal melanoma 04/2008
1	Mitochondrial Diseases (Mitochondrial Disease) 04/2008
1	Body Weight (Weight, Body) 10/2005
1	Necrosis 12/2004
1	Corneal Neovascularization 12/2004
1	Melanoma (Melanoma, Malignant) 09/2004

Drug/Important Bio-Agent (IBA)

10	Vitamin D FDA LinkGeneric 07/2008 - 01/2002
9	CalciumIBA 12/2010 - 01/2002
7	Pharmaceutical PreparationsIBA 04/2008 - 01/2002
4	Calcitriol (Calcijex)FDA LinkGeneric 12/2007 - 05/2002
3	ResveratrolIBA 05/2011 - 09/2007
3	1 alpha-hydroxyergocalciferol (doxercalciferol)FDA Link 12/2007 - 05/2002
2	Cholecalciferol (Vitamin D3)FDA Link 12/2007 - 09/2004
2	Calcitriol Receptors (Calcitriol Receptor)IBA 12/2007 - 09/2002
2	Tumor Viral Antigens (Large T Antigen)IBA 10/2005 - 09/2004
2	beta Subunit Luteinizing HormoneIBA 09/2002 - 01/2002
2	Ergocalciferols (Ergocalciferol)FDA LinkGeneric 09/2002 - 05/2002
1	Blood Glucose (Blood Sugar)IBA 08/2015
1	Insulin (Novolin)FDA Link 08/2015
1	Biomarkers (Surrogate Marker)IBA 08/2015
1	LipidsIBA 08/2015
1	DiglyceridesIBA 08/2015
1	Hormones (Hormone)IBA 08/2015
1	CytokinesIBA 12/2011
1	Toll-Like Receptor AgonistsIBA 12/2011
1	Interleukin-23 (Interleukin 23)IBA 12/2011
1	LipopolysaccharidesIBA 12/2011
1	PolyphenolsIBA 05/2011
1	1,25-dihydroxyvitamin DIBA 12/2010
1	25-hydroxyvitamin DIBA 12/2010
1	Omeprazole (Prilosec)FDA LinkGeneric 12/2010
1	Proton Pump InhibitorsIBA 12/2010
1	Indicators and Reagents (Reagents)IBA 03/2010
1	AndrogensIBA 10/2009
1	Polyamine OxidaseIBA 10/2009
1	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2009
1	Cytochromes c (Cytochrome c)IBA 04/2008
1	5,5',6,6'- tetrachloro- 1,1',3,3'- tetraethylbenzimidazolocarbocyanineIBA 04/2008
1	CaspasesIBA 04/2008
1	Coloring Agents (Dyes)IBA 04/2008
1	RetinoidsIBA 07/2006
1	Estrogens (Estrogen)FDA Link 07/2006
1	LG 100268IBA 07/2006
1	Tamoxifen FDA LinkGeneric 07/2006
1	Bexarotene (LGD1069)FDA Link 07/2006
1	Luteinizing Hormone (Lutropin)FDA LinkGeneric 10/2005
1	2-methylene-19-nor-(20S)-1 alpha-hydroxy-bishomopregnacalciferolIBA 10/2005
1	methylureaIBA 07/2005
1	CarcinogensIBA 07/2005
1	9,10-Dimethyl-1,2-benzanthraceneIBA 07/2005
1	LigandsIBA 12/2004
1	Peptides (Polypeptides)IBA 12/2004
1	Proteins (Proteins, Gene)FDA Link 12/2004
1	Interleukin-12 (IL 12)IBA 12/2004
1	Integrin alphaVbeta3IBA 12/2004
1	Interleukin-12 Receptors (Interleukin 12 Receptor)IBA 12/2004
1	InterleukinsIBA 12/2004
1	Monophenol Monooxygenase (Tyrosinase)IBA 09/2004
1	SilverIBA 09/2004
1	Ribonucleotide Reductases (Ribonucleotide Reductase)IBA 08/2004
1	5-bromo-4-chloro-3-indolyl beta-galactoside (X-gal)IBA 08/2004
1	Antineoplastic Agents (Antineoplastics)IBA 10/2003
1	TransferasesIBA 10/2003
1	Bromodeoxyuridine (BrdU)IBA 10/2003
1	ParaffinIBA 10/2003
1	Codon (Codons)IBA 01/2003

Therapy/Procedure

4	Therapeutics 02/2011 - 08/2004
1	Caloric Restriction 01/2017
1	Liver Transplantation 11/2010
1	Hormone Replacement Therapy (Therapy, Hormone Replacement) 06/2009
1	Oral Administration 04/2008
1	Chemoprevention 07/2006
1	Intraocular Injections 08/2004
1	Ligation 10/2003